Trypsin-like serine protease inhibitors, and their preparation and use

US8207378B2 · kind B2 · utility

Assignee

• THE MEDICINES COMPANY (LEIPZIG) GMBH · DE

Inventors

• Torsten Steinmetzer · Jena, DE
• Andrea Schweinitz · Jena, DE
• Joerg Stuerzebecher · Erfurt, DE
• Peter Steinmetzer · Jena, DE
• Anett Soeffing · Weimar, DE
• Andreas Van De Locht · Munich, DE
• Silke Nicklisch · Leipzig, DE
• Claudia Reichelt · Leipzig, DE
• Friedrich-Alexander Ludwig · Leipzig, DE
• Alexander Schulze · Bad Liebenwerda, DE
• Mohammed Daghisch · Leipzig, DE
• Jochen Heinicke · Leipzig, DE

Key dates

• Filing date: Apr 24, 2009
• Grant date: Jun 26, 2012
• Expiry date: May 14, 2030

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K5/06086
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The invention relates to inhibitors of trypsin-like serine proteases of the general formula (I) which, as well as plasmin, also inhibit plasma kallikrien, and to their preparation and use as medicaments, preferably for treatment of blood loss, especially in the case of hyperfibrinolytic states, in organ transplants or heart surgery interventions, in particular with a cardiopulmonary bypass, or as a constituent of a fibrin adhesive.